Hebei Changshan Biochemical Pharmaceutical Co (SZSE:300255) EPS (Basic) : ¥-0.20 (TTM As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Hebei Changshan Biochemical Pharmaceutical Co EPS (Basic)?

Hebei Changshan Biochemical Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was ¥0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-0.20.

Hebei Changshan Biochemical Pharmaceutical Co's EPS (Diluted) for the three months ended in Mar. 2025 was ¥0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-0.20.

Hebei Changshan Biochemical Pharmaceutical Co's EPS without NRI for the three months ended in Mar. 2025 was ¥0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was -0.20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Hebei Changshan Biochemical Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 150.20% per year. The lowest was -64.80% per year. And the median was 11.65% per year.

Hebei Changshan Biochemical Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for Hebei Changshan Biochemical Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hebei Changshan Biochemical Pharmaceutical Co EPS (Basic) Chart

Hebei Changshan Biochemical Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

0.27

0.25

0.02

-1.35

-0.27

Hebei Changshan Biochemical Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial															-0.07	0.02	0.06	-0.28	-

Hebei Changshan Biochemical Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Hebei Changshan Biochemical Pharmaceutical Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-249.478	-	0)	/	923.992
	=	-0.27

Hebei Changshan Biochemical Pharmaceutical Co's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(3.783	-	0)	/	922.588
	=	0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.20

Hebei Changshan Biochemical Pharmaceutical Co (SZSE:300255) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Hebei Changshan Biochemical Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Hebei Changshan Biochemical Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Hebei Changshan Biochemical Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hebei Changshan Biochemical Pharmaceutical Co Ltd (SZSE:300255) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

North of Yinchuan Street, Zhengding New District, Hebei, Shijiazhuang, CHN, 050800

Website

http://www.hbcsbio.com

Hebei Changshan Biochemical Pharmaceutical Co Ltd is a biotech high-tech enterprise. It is mainly engaged in the research, development, production, and sale of heparin series products. Some of the company's products are Reserpine sodium, Hyaluronic acid, Heparinoid, Heparin sodium, Tinzaparin sodium, Aspirin enteric-coated tablets, and Yihaitang.

Executives

Li Zhi Hua	Executives
Wang Jun	Executives
Ding Jian Wen	Directors, executives
Huang Guo Sheng	Executives
Gao Shu Hua	Directors, executives
Chen Xi	Director
Cai Hao	Executives
Ji Sheng Li	Directors, executives
Li Xin	Securities Affairs Representative
Zhang Wei	Secretary Dong
Liu Jian	Executives
Zhang Zhi Ying	Executives
Guo Yan Xing	Supervisors

Hebei Changshan Biochemical Pharmaceutical Co Headlines

No Headlines